Scarica l'app Stockscreener
1.02
2.00%
0.02
Dopo l'orario di chiusura:
1.00
-0.02
-1.96%
Precedente Chiudi:
$1.00
Aprire:
$0.9939
Volume 24 ore:
69,401
Relative Volume:
0.09
Capitalizzazione di mercato:
$4.35M
Reddito:
-
Utile/perdita netta:
$-6.78M
Rapporto P/E:
-0.0239
EPS:
-42.6996
Flusso di cassa netto:
$-4.67M
1 W Prestazione:
+4.07%
1M Prestazione:
+7.30%
6M Prestazione:
-27.66%
1 anno Prestazione:
-9.73%
Intervallo 1D:
$0.98
$1.0345
Intervallo di 1 settimana:
$0.9504
$1.0345
Portata 52W:
$0.80
$2.18
Clearmind Medicine Inc Stock (CMND) Company Profile
Nome
Clearmind Medicine Inc
Settore
Industria
Telefono
-
Indirizzo
-
Confronta CMND con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CMND
Clearmind Medicine Inc
|
1.02 | 5.38M | 0 | -6.78M | -4.67M | -42.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Clearmind Medicine Inc Borsa (CMND) Ultime notizie
Why Clearmind Medicine Inc. stock attracts strong analyst attentionBreakout Stocks with Huge Upside - thegnnews.com
Should you wait for a breakout in Clearmind Medicine Inc.Volatility Analysis and Entry Risk Mapping - Newser
Clearmind Medicine Inc. stock trendline breakdownFree Accurate Technical Trend Reversal Picks - Newser
Trend analysis for Clearmind Medicine Inc. this weekFree Target Return Focused Trade Insights - Newser
Clearmind Medicine Inc. stock chart pattern explainedDaily Technical Chart Pattern Analysis Report - Newser
What makes Clearmind Medicine Inc. stock price move sharplyFree Reliable Chart-Based Trade Entries - Newser
Can Clearmind Medicine Inc. rally from current levelsHigh Return Trade Roadmap with Setup Filters - Newser
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar - MarketScreener
Risk vs reward if holding onto Clearmind Medicine Inc.3-Year Equity Summary With Setup Insights - Newser
Clearmind Medicine Inc. stock retracement – recovery analysis5-Year Price Trend Summary and Analysis - Newser
Can a trend reversal in Clearmind Medicine Inc. lead to recoveryEntry Zone Forecast for Momentum Trading - Newser
Short interest data insights for Clearmind Medicine Inc.Entry Confirmation Based on Volatility Analysis - Newser
Institutional scanner results for Clearmind Medicine Inc.High Win Rate Strategy with Stop Protection - Newser
Can you recover from losses in Clearmind Medicine Inc.Daily Stock Watch Summary with Key Insights - Newser
Will Clearmind Medicine Inc. benefit from macro trendsMomentum-Based Prediction for Quick Returns - Newser
Can volume confirm reversal in Clearmind Medicine Inc.Real Market Tracker with Price Action Tools - Newser
Is it time to cut losses on Clearmind Medicine Inc.Buy List With Technical Entry Triggers - Newser
Published on: 2025-08-09 23:23:05 - Newser
How Clearmind Medicine Inc. stock performs during market volatilityFree Community Entry Consensus Trade Ideas - Newser
How to use a screener to detect Clearmind Medicine Inc. breakoutsTrend Analysis for Safer Market Entries - Newser
How Clearmind Medicine Inc. stock reacts to Fed policy changesHigh Win Rate Trading Opportunities Detected - metal.it
Clearmind Medicine Inc. stock outlook for YEARTechnical Insight Guide for Safer Trades - Newser
SciSparc-Clearmind collab leads to international patent application - TipRanks
Clearmind announces publication of international patent application under PCT - TipRanks
Clearmind announces patent application for metabolic syndrome treatment - Investing.com
Clearmind announces patent application for metabolic syndrome treatment By Investing.com - Investing.com South Africa
SciSparc-Clearmind Collaboration Leads to Publication of - GlobeNewswire
Breakthrough Obesity Treatment Patent Targets One-Third of US Adults with Metabolic Syndrome - Stock Titan
Exit strategy if you’re trapped in Clearmind Medicine Inc.Free Investment Playbook for Growing Markets - Newser
Does Clearmind Medicine Inc. show high probability of reboundWeekly Breakout Forecast with Entry Zones - Newser
Clearmind Medicine Inc Azioni (CMND) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):